Clinical trials
Expanded access Immune System Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
No trials to chart.
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| No longer available | 3 |
| Approved for marketing | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Christopher Dvorak | 1 |
| Ellodi Pharmaceuticals, LP | 1 |
| Regeneron Pharmaceuticals | 1 |
| UNC Lineberger Comprehensive Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immune System Diseases | 4 |
| Hematologic Diseases | 2 |
| Immunoproliferative Disorders | 2 |
| Leukemia | 2 |
| Leukocyte Disorders | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Autoimmune Diseases | 1 |
| Bone Diseases | 1 |
| Bone Diseases, Developmental | 1 |
| Bone Marrow Diseases | 1 |
Trials
Showing 26 to 4 of 4. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.